QUEST DIAGNOSTICS ($DGX) posted quarterly earnings results on Tuesday, October 21st. The company reported earnings of $2.60 per share, beating estimates of $2.53 by $0.07. The company also reported revenue of $2,816,000,000, beating estimates of $2,763,631,841 by $52,368,159.
You can see Quiver Quantitative's $DGX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
QUEST DIAGNOSTICS Insider Trading Activity
QUEST DIAGNOSTICS insiders have traded $DGX stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $DGX stock by insiders over the last 6 months:
- MICHAEL E PREVOZNIK (SVP & General Counsel) has made 0 purchases and 4 sales selling 28,690 shares for an estimated $5,368,747.
- PATRICK PLEWMAN (SVP for Diagnostic Services) has made 0 purchases and 5 sales selling 14,017 shares for an estimated $2,518,856.
- KARTHIK KUPPUSAMY (SVP, Clinical Solutions) has made 0 purchases and 3 sales selling 10,479 shares for an estimated $1,759,930.
- MARK E DELANEY (SVP & Chief Commercial Officer) has made 0 purchases and 2 sales selling 1,748 shares for an estimated $306,800.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
QUEST DIAGNOSTICS Hedge Fund Activity
We have seen 454 institutional investors add shares of QUEST DIAGNOSTICS stock to their portfolio, and 422 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,210,459 shares (+20.2%) to their portfolio in Q2 2025, for an estimated $217,434,750
- DAVIS SELECTED ADVISERS removed 1,033,882 shares (-43.3%) from their portfolio in Q2 2025, for an estimated $185,716,223
- NORDEA INVESTMENT MANAGEMENT AB removed 1,029,219 shares (-81.9%) from their portfolio in Q2 2025, for an estimated $184,878,608
- M&G PLC added 771,824 shares (+256.5%) to their portfolio in Q2 2025, for an estimated $138,642,745
- BOSTON PARTNERS added 739,407 shares (+32.2%) to their portfolio in Q2 2025, for an estimated $132,819,679
- SQUAREPOINT OPS LLC added 688,297 shares (+444.1%) to their portfolio in Q2 2025, for an estimated $123,638,790
- JPMORGAN CHASE & CO added 561,722 shares (+14.9%) to their portfolio in Q2 2025, for an estimated $100,902,122
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
QUEST DIAGNOSTICS Government Contracts
We have seen $92,659,595 of award payments to $DGX over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- PRIMARY REFERENCE LABORATORY TESTING / COURIER SERVICES / PHLEBOTOMY: $8,400,000
- TASK ORDER FOR REF LAB BRIDGE WHILE SOLIITATION IS CURRENTLY ACTIVE TO AVOID SERVICE DISRUPTION.: $8,183,000
- REFERENCE LAB TESTS: $3,748,684
- REFERENCE LAB TESTING - OPTION 2: $3,375,189
- VISN 6 REFERENCE LAB TESTING AND COURIER SERVICES: $2,399,999
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
QUEST DIAGNOSTICS Analyst Ratings
Wall Street analysts have issued reports on $DGX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 10/17/2025
To track analyst ratings and price targets for QUEST DIAGNOSTICS, check out Quiver Quantitative's $DGX forecast page.
QUEST DIAGNOSTICS Price Targets
Multiple analysts have issued price targets for $DGX recently. We have seen 9 analysts offer price targets for $DGX in the last 6 months, with a median target of $190.0.
Here are some recent targets:
- Kevin Caliendo from UBS set a target price of $190.0 on 10/17/2025
- Ann Hynes from Mizuho set a target price of $210.0 on 10/17/2025
- Elizabeth Anderson from Evercore ISI Group set a target price of $190.0 on 10/08/2025
- Stephanie Davis from Barclays set a target price of $190.0 on 10/02/2025
- Eric Coldwell from Baird set a target price of $194.0 on 08/25/2025
- David Macdonald from Truist Securities set a target price of $192.0 on 07/23/2025
- Pito Chickering from Deutsche Bank set a target price of $178.0 on 07/23/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
